PENUMBRA INC (PEN)
US70975L1070 - Common Stock
PEN gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 193 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making PEN a very profitable company, without any liquidiy or solvency issues. PEN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, PEN could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
PEN had positive earnings in the past year.
PEN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PEN reported negative net income in multiple years.
In multiple years PEN reported negative operating cash flow during the last 5 years.
1.2 Ratios
PEN's Return On Assets of 5.85% is amongst the best of the industry. PEN outperforms 84.90% of its industry peers.
The Return On Equity of PEN (7.72%) is better than 80.73% of its industry peers.
With a decent Return On Invested Capital value of 5.16%, PEN is doing good in the industry, outperforming 78.65% of the companies in the same industry.
PEN had an Average Return On Invested Capital over the past 3 years of 2.28%. This is significantly below the industry average of 8.53%.
The last Return On Invested Capital (5.16%) for PEN is above the 3 year average (2.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.85% | ||
| ROE | 7.72% | ||
| ROIC | 5.16% |
ROA(3y)2.04%
ROA(5y)2.3%
ROE(3y)2.69%
ROE(5y)3.12%
ROIC(3y)2.28%
ROIC(5y)N/A
1.3 Margins
PEN has a better Profit Margin (8.60%) than 82.29% of its industry peers.
In the last couple of years the Profit Margin of PEN has grown nicely.
The Operating Margin of PEN (8.67%) is better than 76.56% of its industry peers.
PEN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 64.50%, PEN is in the better half of the industry, outperforming 66.15% of the companies in the same industry.
PEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.67% | ||
| PM (TTM) | 8.6% | ||
| GM | 64.5% |
OM growth 3YN/A
OM growth 5Y5.22%
PM growth 3YN/A
PM growth 5Y42.09%
GM growth 3Y2.24%
GM growth 5Y-0.38%
2. Health
2.1 Basic Checks
PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PEN has been increased compared to 1 year ago.
Compared to 5 years ago, PEN has more shares outstanding
The debt/assets ratio for PEN has been reduced compared to a year ago.
2.2 Solvency
PEN has an Altman-Z score of 14.26. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 14.26, PEN belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
The Debt to FCF ratio of PEN is 0.32, which is an excellent value as it means it would take PEN, only 0.32 years of fcf income to pay off all of its debts.
PEN has a Debt to FCF ratio of 0.32. This is amongst the best in the industry. PEN outperforms 93.75% of its industry peers.
PEN has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, PEN is in the better half of the industry, outperforming 64.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.32 | ||
| Altman-Z | 14.26 |
ROIC/WACC0.52
WACC9.96%
2.3 Liquidity
PEN has a Current Ratio of 6.06. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PEN (6.06) is better than 79.17% of its industry peers.
A Quick Ratio of 3.49 indicates that PEN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.49, PEN is in the better half of the industry, outperforming 64.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.06 | ||
| Quick Ratio | 3.49 |
3. Growth
3.1 Past
PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1129.41%, which is quite impressive.
Measured over the past years, PEN shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.59% on average per year.
The Revenue has grown by 24.95% in the past year. This is a very strong growth!
PEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.93% yearly.
EPS 1Y (TTM)1129.41%
EPS 3Y126.44%
EPS 5Y32.59%
EPS growth Q2Q375%
Revenue 1Y (TTM)24.95%
Revenue growth 3Y23.61%
Revenue growth 5Y18.93%
Revenue growth Q2Q28.7%
3.2 Future
Based on estimates for the next years, PEN will show a very strong growth in Earnings Per Share. The EPS will grow by 29.17% on average per year.
The Revenue is expected to grow by 14.30% on average over the next years. This is quite good.
EPS Next Y36.69%
EPS Next 2Y36.46%
EPS Next 3Y35.57%
EPS Next 5Y29.17%
Revenue Next Year17.37%
Revenue Next 2Y17%
Revenue Next 3Y16.74%
Revenue Next 5Y14.3%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 99.78, which means the current valuation is very expensive for PEN.
Based on the Price/Earnings ratio, PEN is valued a bit cheaper than 68.23% of the companies in the same industry.
When comparing the Price/Earnings ratio of PEN to the average of the S&P500 Index (28.28), we can say PEN is valued expensively.
Based on the Price/Forward Earnings ratio of 73.00, the valuation of PEN can be described as expensive.
Based on the Price/Forward Earnings ratio, PEN is valued a bit cheaper than the industry average as 70.83% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 20.88. PEN is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 99.78 | ||
| Fwd PE | 73 |
4.2 Price Multiples
67.71% of the companies in the same industry are more expensive than PEN, based on the Enterprise Value to EBITDA ratio.
PEN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PEN is cheaper than 72.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 98.28 | ||
| EV/EBITDA | 63.79 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEN has a very decent profitability rating, which may justify a higher PE ratio.
PEN's earnings are expected to grow with 35.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.72
PEG (5Y)3.06
EPS Next 2Y36.46%
EPS Next 3Y35.57%
5. Dividend
5.1 Amount
No dividends for PEN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PENUMBRA INC
NYSE:PEN (5/3/2024, 7:11:44 PM)
After market: 208.55 0 (0%)208.55
+2.49 (+1.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.08B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 99.78 | ||
| Fwd PE | 73 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.72
PEG (5Y)3.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.85% | ||
| ROE | 7.72% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 8.67% | ||
| PM (TTM) | 8.6% | ||
| GM | 64.5% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 6.06 | ||
| Quick Ratio | 3.49 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1129.41%
EPS 3Y126.44%
EPS 5Y
EPS growth Q2Q
EPS Next Y36.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)24.95%
Revenue growth 3Y23.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y